Diurnal variation of 6β-hydroxycortisol in cardiac patients

Physiological Research

Volumn 56, Issue 3, 2007, Pages 307-313

  Mičuda, Stanislav ^a   Sispera L ^a   Hodac M ^a   Parizek P ^a   Fuksa, L ^a   Brcakova E ^a   Cerman, J ^a   Cermanova J ^a   Martinkova J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

6 hydroxycortisol; Cortisol; CYP3A4; Diurnal variation

Indexed keywords

6 BETA-HYDROXYCORTISOL; 6BETA HYDROXYHYDROCORTISONE; CYTOCHROME P450 3A; DRUG DERIVATIVE; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; EVALUATION; HEART DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP3A; HEART DISEASES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 34547140726     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BARRETT YC, AKINSANYA B, CHANG SY, VESTERQVIST O: Automated on-line SPE LC-MS/MS method to quantitate 6β-hydroxycortisol and cortisol in human urine: use of the 6β-hydroxycortisol to cortisol ratio as an indicator of CYP3A4 activity. J Chromatogr B Analyt Technol Biomed Life Sci 821: 159-165, 2005.
2. BIENVENU T, REY E, PONS G, D'ATHIS P, OLIVE G: A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans. Int J Clin Pharmacol Ther Toxicol 29: 441-445, 1991.
3. BURSTEIN S, KIMBALL HL, KLAIBER EL, GUT M: Metabolism of 2-alpha- and 6-beta-hydroxycortisol in man: determination of production rates of 6-beta-hydroxycortisol with and without phenobarbital administration. J Clin Endocrinol Metab 27: 491-499, 1967.
4. GALTEAU MM, SHAMSA F: Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol 59: 713-733, 2003.
5. GED C, ROUILLON JM, PICHARD L, COMBALBERT J, BRESSOT N, BORIES P, MICHEL H, BEAUNE P, MAUREL P: The increase in urinary excretion of 6β- hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol 28: 373-387, 1989.
6. GUENGERICH FP: Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39: 1-17, 1999.
7. INOUE S, INOKUMA M, HARADA T, SHIBUTANI Y, YOSHITAKE T, CHARLES B, ISHIDA J, YAMAGUCHI M: Simultaneous high-performance liquid chromatographic determination of 6β-hydroxycortisol and cortisol in urine with fluorescence detection and its application for estimating hepatic drug-metabolizing enzyme induction. J Chromatogr B Biomed Appl 661: 15-23, 1994.
8. JOELLENBECK L, QIAN Z, ZARBA A, GROOPMAN JD: Urinary 6β- hydroxycortisol/cortisol ratios measured by high-performance liquid chromatography for use as a biomarker for the human cytochrome P-450 3A4. Cancer Epidemiol Biomarkers Prev 1: 567-572, 1992.
9. KOLARS JC, SCHMIEDLIN-REN P, SCHUETZ JD, FANG C, WATKINS PB: Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 90: 1871-1878, 1992.
10. KOVACS SJ, MARTIN DE, EVERITT DE, PATTERSON SD, JORKASKY DK: Urinary excretion of 6β-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations. Clin Pharmacol Ther 63: 617-622, 1998.
11. LAMBA JK, LIN YS, SCHUETZ EG, THUMMEL KE: Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 54: 1271-1294, 2002.
12. LEE C: Urinary 6β-hydroxycortisol in humans: analysis, biological variations, and reference ranges. Clin Biochem 28: 49-54, 1995.
13. LYKKESFELDT J, LOFT S, POULSEN HE: Simultaneous determination of urinary free cortisol and 6β-hydroxycortisol by high-performance liquid chromatography to measure human CYP3A activity. J Chromatogr B Biomed Appl 660: 23-29, 1994.
14. MCCUNE JS, LINDLEY C, SAWYER WT, WILLIAMSON K, KASHUBA A, PIEPER JA: Comparison of 24 hour and morning 6βOH cortisol:cortisol ratio in men, women on oral contraceptives and women not on oral contraceptive. Clin Pharmacol Ther 63: 219, 1998.
15. MIČUDA S, HODAČ M, ŠIŠPERA L, PAŘemptyv;ÍZEK P, PLESKOT M, ZIMOVÁ G, CERMAN J, MARTÍNKOVÁ J, PIDRMAN V: Influence of amiodarone on urinary excretion of 6β-hydroxycortisol in humans. Physiol Res 50: 191-196, 2001.
16. NAKAMURA J, YAKATA M: Assessing adrenocortical activity by determining levels of urinary free cortisol and urinary 6β-hydroxycortisol. Acta Endocrinol (Copenh) 120: 277-283, 1989.
17. NAKAMURA H, YAMAGATA S, SAWAI M, NAKAMURA H, OHMORI S, KITADA M: Effects of grapefruit juice on the urinary 6β-cortisol/cortisol ratio. Jpn J Hosp Pharm 23: 134-139, 1997.
18. OHNHAUS EE, BRECKENRIDGE AM, PARK BK: Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol 36: 39-46, 1989.
19. OHNO M, YAMAGUCHI I, ITO T, SAIKI K, YAMAMOTO I, AZUMA J: Circadian variation of the urinary 6β-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity. Eur J Clin Pharmacol 55: 861-865, 2000.
20. ONO T, TANIDA K, SHIBATA H, KONISHI H, SHIMAKAWA H: High-performance liquid chromatographic determination of 6β-hydroxycortisol in urine. Chem Pharm Bull (Tokyo) 34: 2522-2527, 1986.
21. PARK BK: A direct radioimmunoassay for 6β-hydroxycortisol in human urine. J Steroid Biochem 9: 963-966, 1978.
22. SAENGER P: 6β-hydroxycortisol in random urine samples as an indicator of enzyme induction. Clin Pharmacol Ther 34: 818-821, 1983.
23. SHIMADA T, YAMAZAKI H, MIMURA M, INUI Y, GUENGERICH FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270: 414-423, 1994.
24. THUMMEL KE, O'SHEA D, PAINE MF, SHEN DD, KUNZE KL, PERKINS JD, WILKINSON GR: Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 59: 491-502, 1996.
25. TRAN JQ, KOVACS SJ, MCINTOSH TS, DAVIS HM, MARTIN DE: Morning spot and 24-hour urinary 6β-hydroxycortisol to cortisol ratios: intraindividual variability and correlation under basal conditions and conditions of CYP 3A4 induction. J Clin Pharmacol 39: 487-494, 1999.
26. VON RICHTER O, BURK O, FROMM MF, THON KP, EICHELBAUM M, KIVISTO KT: Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 75: 172-183, 2004.
27. WANG A, YU BN, LUO CH, TAN ZR, ZHOU G, WANG LS, ZHANG W, LI Z, LIU J, ZHOU HH: Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients. Eur J Clin Pharmacol 60: 843-848, 2005.
28. WATKINS PB, MURRAY SA, WINKELMAN LG, HEUMAN DM, WRIGHTON SA, GUZELIAN PS: Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J Clin Invest 83: 688-697, 1989.
29. ZHIRI A, WELLMAN-BEDNAWSKA M, SIEST G: ELISA of 6β-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy. Clin Chim Acta 157: 267-276, 1986.